Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $395 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a price target of $395.
October 01, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated a Neutral rating for Humana, maintaining a price target of $395. This suggests that the analyst does not expect significant short-term price movement.
The reiteration of a Neutral rating and maintenance of the price target at $395 by Cantor Fitzgerald indicates that the analyst does not foresee significant changes in Humana's stock price in the short term. This suggests stability in the company's current valuation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100